المؤلفون: El Bakkouri, Majida, Kouidmi, Imène, Wernimont, Amy, Amani, Mehrnaz, Hutchinson, Ashley, Loppnau, Peter, Kim, Jeong Joo, Flueck, Christian, Walker, John, Seitova, Alma, Senisterra, Guillermo, Kakihara, Yoshito, Kim, Choel, Blackman, Michael, Calmettes, Charles, Baker, David, Hui, Raymond

المساهمون: University of Toronto, Institut Armand Frappier (INRS-IAF), Institut National de la Recherche Scientifique Québec (INRS)-Réseau International des Instituts Pasteur (RIIP), Baylor College of Medicine (BCM), Baylor University, London School of Hygiene and Tropical Medicine (LSHTM), The Francis Crick Institute London, Toronto General Hospital Research Institute Canada (TGHRI), University Health Network Toronto, ON, Canada, The Structural Genomics Consortium is a registered charity (no. 1097737) that receives funds from AbbVie, Boehringer Ingelheim, the Canada Foundation for Innovation, the Canadian Institutes for Health Research, Genome Canada through the Ontario Genomics Institute (OGI-055), GlaxoSmithKline, Janssen, Lilly Canada, the Novartis Research Foundation, the Ontario Ministry of Economic Development and Innovation, Pfizer, Takeda, and the Wellcome Trust. This work was also supported by Wellcome Trust Grants 092809/Z/10/Z, 106240/Z/14/Z and 106239/Z/14/A (to D.A.B. and M.J.B.). This work was also supported by the Francis Crick Institute (M.J.B.) , which receives its core funding from Cancer Research UK Grant FC001043, UK Medical Research Council Grant FC001043, and Wellcome Trust Grant FC001043. C.C. is the recipient of Fonds de Recherche Québec–Santé (FRQS) Research Scholar Junior 1 Career Award 251848, supported by Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant RGPIN-2017-06091, Fonds de Recherche Québec–Nature et Technologies (FRQNT) Grant 2019-NC-253753, as well as with instrumentation and infrastructure support provided by the Armand–Frappier Foundation. This research used resources of the Canadian Light Source at Beamline 08ID-1, which is supported by the Canada Foundation for Innovation, Natural Sciences and Engineering Research Council of Canada, and Canadian Institutes of Health Research, and of the Advanced Photon Source, a US Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract DE-AC02-06CH11357.

المصدر: ISSN: 0027-8424.

مصطلحات موضوعية: Plasmodium, cyclic GMP, malaria, signal transduction, structure, [SDV]Life Sciences [q-bio], [SDV.MP]Life Sciences [q-bio]/Microbiology and Parasitology, [SDV.BBM]Life Sciences [q-bio]/Biochemistry, Molecular Biology

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/31239348; pasteur-02273418; https://riip.hal.science/pasteur-02273418Test; PUBMED: 31239348; PUBMEDCENTRAL: PMC6628679

الإتاحة: https://doi.org/10.1073/pnas.1905558116Test
https://riip.hal.science/pasteur-02273418Test

المؤلفون: El Bakkouri, Majida, Kouidmi, Imène, Wernimont, Amy, Amani, Mehrnaz, Hutchinson, Ashley, Loppnau, Peter, Kim, Jeong Joo, Flueck, Christian, Walker, John, Seitova, Alma, Senisterra, Guillermo, Kakihara, Yoshito, Kim, Choel, Blackman, Michael, Calmettes, Charles, Baker, David, Hui, Raymond

المساهمون: University of Toronto, Institut Armand Frappier (INRS-IAF), Institut National de la Recherche Scientifique Québec (INRS)-Réseau International des Instituts Pasteur (RIIP), Baylor College of Medicine (BCM), Baylor University, London School of Hygiene and Tropical Medicine (LSHTM), The Francis Crick Institute London, Toronto General Hospital Research Institute Canada (TGHRI), The Structural Genomics Consortium is a registered charity (no. 1097737) that receives funds from AbbVie, Boehringer Ingelheim, the Canada Foundation for Innovation, the Canadian Institutes for Health Research, Genome Canada through the Ontario Genomics Institute (OGI-055), GlaxoSmithKline, Janssen, Lilly Canada, the Novartis Research Foundation, the Ontario Ministry of Economic Development and Innovation, Pfizer, Takeda, and the Wellcome Trust. This work was also supported by Wellcome Trust Grants 092809/Z/10/Z, 106240/Z/14/Z and 106239/Z/14/A (to D.A.B. and M.J.B.). This work was also supported by the Francis Crick Institute (M.J.B.) , which receives its core funding from Cancer Research UK Grant FC001043, UK Medical Research Council Grant FC001043, and Wellcome Trust Grant FC001043. C.C. is the recipient of Fonds de Recherche Québec–Santé (FRQS) Research Scholar Junior 1 Career Award 251848, supported by Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant RGPIN-2017-06091, Fonds de Recherche Québec–Nature et Technologies (FRQNT) Grant 2019-NC-253753, as well as with instrumentation and infrastructure support provided by the Armand–Frappier Foundation. This research used resources of the Canadian Light Source at Beamline 08ID-1, which is supported by the Canada Foundation for Innovation, Natural Sciences and Engineering Research Council of Canada, and Canadian Institutes of Health Research, and of the Advanced Photon Source, a US Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract DE-AC02-06CH11357.

المصدر: ISSN: 0027-8424.

مصطلحات موضوعية: signal transduction, structure, Plasmodium, cyclic GMP, malaria, [SDV]Life Sciences [q-bio], [SDV.MP]Life Sciences [q-bio]/Microbiology and Parasitology, [SDV.BBM]Life Sciences [q-bio]/Biochemistry, Molecular Biology

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/31239348; pasteur-02273418; https://hal-riip.archives-ouvertes.fr/pasteur-02273418Test; PUBMED: 31239348; PUBMEDCENTRAL: PMC6628679

الإتاحة: https://doi.org/10.1073/pnas.1905558116Test
https://hal-riip.archives-ouvertes.fr/pasteur-02273418Test